Thrombosis risk assessment in patients with congenital thrombophilia during COVID - 19 infection.

ABSTRACT:

Background

Coagulation dysfunction represents a serious complication in patients during the COVID-19 infection, while fulminant thrombotic complications emerge as critical issues in individuals with severe COVID-19. In addition to a severe clinical presentation, comorbidities and age significantly contribute to the development of thrombotic complications in this disease. However, there is very little data on association of congenital thrombophilia and thrombotic events in the setting of COVID-19. Our study aimed to evaluate the risk of COVID-19 associated thrombosis in patients with congenital thrombophilia.

Methods

This prospective, case-control study included patients with confirmed COVID-19 infection, followed 6 months post-confirmation. The final outcome was a symptomati

SUBMITTER: Kovac M 

PROVIDER: S-EPMC9392558 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature